Show simple item record

dc.contributor.authorRedick, Thomas P
dc.date.accessioned2017-06-07T17:49:26Z
dc.date.available2017-06-07T17:49:26Z
dc.date.issued2005
dc.identifier.urihttps://hdl.handle.net/1813/51012
dc.description.abstractThere are regulatory and liability hurdles standing in the way of launching a new transgenic product. Despite past successes, and the knowledge gained from failures and near misses, the road to future commercial success in agricultural biotechnology remains fraught with difficulties. US agricultural biotechnology operations will need to maintain perfect divisions between its “green,” “white” and “red” sectors—food and feed, plant-pharmaceutical, and industrial applications.
dc.language.isoen_US
dc.publisherNABC
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 International*
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.subjectAgricultural biotechnology
dc.subjectenvironment, human health
dc.subjectGMO, genetic engineering, pharming
dc.subjectplant based vaccines
dc.subjectmedicinals
dc.subjectregulation
dc.subjectliability, patents
dc.subjectstewardship
dc.titleLiability prevention and biotechnology: A brief history of successful industrial stewardship
dc.typebook chapter


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record

Except where otherwise noted, this item's license is described as Attribution-NonCommercial-NoDerivatives 4.0 International

Statistics